Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In Vitro Susceptibility Testing of a Novel Benzimidazole, SPR719, against Nontuberculous Mycobacteria

17 Aug 2018

Abstract excerpt

Nontuberculous mycobacterium (NTM) infections are increasing globally. The Mycobacterium avium complex (MAC) and Mycobacterium abscessus are the most frequently encountered NTM among clinical laboratories, and treatment options are extremely limited.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Infectious Diseases and Mycology
Share to Mycobacterium research and diagnosis
Share to Tuberculosis Research and Epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30126964
DOI: 10.1128/aac.01503-18

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In Vitro Susceptibility Testing of a Novel Benzimidazole, SPR719, against Nontuberculous MycobacteriaPMID 30126964Read ↗

In vitro activity of SPR719 against Mycobacterium ulcerans, Mycobacterium marinum and Mycobacterium chimaera.Semantic proximity Read ↗

In Vitro Resistance against DNA Gyrase Inhibitor SPR719 in Mycobacterium avium and Mycobacterium abscessus.Semantic proximity Read ↗

Drug Susceptibility Testing of Nontuberculous MycobacteriaSemantic proximity Read ↗

In vitro susceptibility patterns for rapidly growing nontuberculous mycobacteria in the United StatesSemantic proximity Read ↗

Drug susceptibility of the Mycobacterium genus: in vitro tests and clinical implications.Semantic proximity Read ↗

Advancement of GyrB Inhibitors for Treatment of Infections Caused by Mycobacterium tuberculosis and Non-tuberculous MycobacteriaSemantic proximity Read ↗

Variability of Mycobacterium avium Complex Isolates Drug Susceptibility Testing by Broth MicrodilutionSemantic proximity Read ↗

Activity of LCB01-0371, a Novel Oxazolidinone, against Mycobacterium abscessusSemantic proximity Read ↗

New exploration of the treatment of nontuberculous mycobacterium lung disease: Moxifloxacin may be a first-line drug for the treatment of NTM-PDSemantic proximity Read ↗

Pharmacological validation of dihydrofolate reductase as a drug target in Mycobacterium abscessusSemantic proximity Read ↗

Molecular Analysis of Linezolid-Resistant Clinical Isolates of Mycobacterium abscessusSemantic proximity Read ↗

Rational Exploration of 2,4-Diaminopyrimidines as DHFR Inhibitors Active against Mycobacterium abscessus and Mycobacterium avium, Two Emerging Human PathogensSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.